What exactly have we met? Not one generic has been launched since Nasrat came with his 12 ANDAS. Broken deadlines. What happened to the once a day starting in March/April, what about Isradipine launching in April? If you look at it, Nasrat really hasn't done anything the whole year but start a pivotal trial for Eli201 that he said we would have results for in October and still no word and also the HAL data for Eli200.
Market Data 
Markets 
